World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
113
Citations
81640
World Ranking
422
National Ranking
258

Medicine

D-Index
113
Citations
81640
World Ranking
4827
National Ranking
2618

H. Clifford Lane publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where H. Clifford Lane sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 348 publications — 73rd percentile

73% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

H. Clifford Lane D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where H. Clifford Lane sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 113 D-Index — 91st percentile

91% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Research.com Recognitions

  • 2006 - Member of the National Academy of Medicine (NAM)
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians
  • Member of the Association of American Physicians

Overview

H. Clifford Lane is affiliated with the National Institute of Allergy and Infectious Diseases in the United States. Their research primarily focuses on the field of Medicine, with 166 documented publications. Within Medicine, key subfields of study include Infectious Diseases, Molecular Biology, Virology, Epidemiology, and Neurology.

Their work covers main topics such as COVID-19 Clinical Research Studies, SARS-CoV-2 and COVID-19 Research, HIV Research and Treatment, Viral Infections and Outbreaks Research, Long-Term Effects of COVID-19, HIV/AIDS drug development and treatment, and HIV/AIDS Research and Interventions.

Frequent publication venues for H. Clifford Lane include the New England Journal of Medicine, Annals of Internal Medicine, The Journal of Infectious Diseases, Neurology, and AIDS. These venues reflect the clinical and biomedical focus of their scholarship.

Key recent papers include:

  • Remdesivir for the Treatment of Covid-19 - Final Report, 2020, New England Journal of Medicine
  • DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update), 2022, Nucleic Acids Research
  • Covid-19 - Navigating the Uncharted, 2020, New England Journal of Medicine
  • COVID-19: towards controlling of a pandemic, 2020, The Lancet
  • A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia, 2020, New England Journal of Medicine

H. Clifford Lane has collaborated extensively with several co-authors, including James D. Neaton, Jens Lundgren, Elizabeth S. Higgs, Robin Dewar, and Cavan Reilly. These collaborations reflect contributions across a variety of clinical and infectious disease research projects.

Awards recognizing Lane's contributions include membership in the National Academy of Medicine (NAM) awarded in 2006 and membership in the Association of American Physicians.

Best Publications

  • DAVID: Database for Annotation, Visualization, and Integrated Discovery

    Glynn Dennis;Brad T. Sherman;Douglas A Hosack;Jun Jun Yang

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Initiation of antiretroviral therapy in early asymptomatic HIV infection

    Sean Emery;Shweta Sharma;Gerd Fätkenheuer;Josep M. Llibre

  • The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists

    Da-Wei Huang;Brad T. Sherman;Qina Tan;Jack R Collins

  • DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists

    Da Wei Huang;Brad T. Sherman;Qina Tan;Joseph Kir

  • Identifying biological themes within lists of genes with EASE

    Douglas A Hosack;Glynn Dennis;Brad T Sherman;H Clifford Lane

  • Covid-19 — Navigating the Uncharted

    Anthony S. Fauci;H. Clifford Lane;Robert R. Redfield

  • Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

    H C Lane;H Masur;L C Edgar;G Whalen

  • Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.

    Lewis H Kuller;Russell Tracy;Waldo Belloso;Stephane De Wit

  • A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics.

    Mulangu S;Dodd Le;Davey Rt;Tshiani Mbaya O

  • COVID-19: towards controlling of a pandemic.

    Juliet Bedford;Delia Enria;Johan Giesecke;David L Heymann

  • DAVID-WS

    Xiaoli Jiao;Brad T. Sherman;Da Wei Huang;Robert Stephens

  • Acquired Immunodeficiency Syndrome: Epidemiologic, Clinical, Immunologic, and Therapeutic Considerations

    A S Fauci;A M Macher;D L Longo;H C Lane

  • Pneumocystis carinii Pneumonia: A Comparison Between Patients with the Acquired Immunodeficiency Syndrome and Patients with Other Immunodeficiencies

    Joseph A. Kovacs;John W. Hiemenz;Abe M. Macher;Diane Stover

  • HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression

    Richard T. Davey;Niranjan Bhat;Christian Yoder;Tae Wook Chun

  • Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition.

    Lane Hc;Depper Jm;Greene Wc;Whalen G

  • The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4

    SM Schnittman;MC Psallidopoulos;HC Lane;L Thompson

  • A Randomized Trial of Convalescent Plasma in Covid-19 Severe Pneumonia.

    Ventura A. Simonovich;Leandro D. Burgos Pratx;Paula Scibona;María V. Beruto

  • Redistribution, Hyperproliferation, Activation of Natural Killer Cells and CD8 T Cells, and Cytokine Production During First-in-Human Clinical Trial of Recombinant Human Interleukin-15 in Patients With Cancer

    Kevin C. Conlon;Enrico Lugli;Hugh C. Welles;Hugh C. Welles;Steven A. Rosenberg

  • Cryptococcosis in the acquired immunodeficiency syndrome.

    Joseph A. Kovacs;Andrea A. Kovacs;Michael Polis;W. Craig Wright

  • Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness.

    A H Rook;J H Kehrl;L M Wakefield;A B Roberts

  • Inflammation, Coagulation and Cardiovascular Disease in HIV-Infected Individuals

    Daniel A. Duprez;Jacqueline Neuhaus;Lewis H. Kuller;Russell Tracy

  • HIV infection induces changes in CD4+ T-cell phenotype and depletions within the CD4+ T-cell repertoire that are not immediately restored by antiviral or immune-based therapies.

    M Connors;J A Kovacs;S Krevat;J C Gea-Banacloche

  • Administration of an Anti-CD8 Monoclonal Antibody Interferes with the Clearance of Chimeric Simian/Human Immunodeficiency Virus during Primary Infections of Rhesus Macaques

    T Matano;R Shibata;C Siemon;M Connors

  • Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals.

    S M Schnittman;H C Lane;J Greenhouse;J S Justement

  • A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.

    Davey Rt;Dodd L;Proschan Ma

  • Risk for occupational transmission of human immunodeficiency virus type 1 (HIV-1) associated with clinical exposures. A prospective evaluation.

    Henderson Dk;Fahey Bj;Willy M;Schmitt Jm

  • Controlled trial of interleukin-2 infusions in patients infected with the human immunodeficiency virus.

    Joseph A. Kovacs;Susan Vogel;Jeffrey M. Albert;Judith Falloon

Frequent Co-Authors

Henry Masur
Henry Masur National Institutes of Health
Richard T. Davey
Richard T. Davey National Institute of Allergy and Infectious Diseases
Joseph A. Kovacs
Joseph A. Kovacs National Institutes of Health
Julia A. Metcalf
Julia A. Metcalf National Institute of Allergy and Infectious Diseases
Anthony S. Fauci
Anthony S. Fauci Georgetown University
Michael Baseler
Michael Baseler Leidos (United States)
Michael A. Polis
Michael A. Polis National Institute of Allergy and Infectious Diseases
Richard A. Lempicki
Richard A. Lempicki National Institute of Allergy and Infectious Diseases
James D. Neaton
James D. Neaton University of Minnesota
Irini Sereti
Irini Sereti National Institutes of Health

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in advancing their knowledge beyond Immunology, there are several related healthcare degree programs available online. Many prospective nurses, for example, seek accessible options such as the easiest absn programs to get into. These accelerated Bachelor of Science in Nursing programs provide a faster pathway for those who already hold a degree in another field.

Those aiming to begin with foundational nursing credentials can explore accredited lpn programs easy to get into. Licensed Practical Nurse programs are known for their shorter duration and practical training focus, which can be ideal for quick entry into the healthcare workforce.

For advanced practice nurses, easiest np program options help learners find nurse practitioner degrees with flexible admissions criteria. These programs enable specialized clinical skills and greater career advancement.

Finally, mental health nursing is a growing field, and students can consider online pmhnp programs with clinical placement to combine remote learning with on-site experience. This approach ensures high-quality training and strong career readiness in psychiatric-mental health nursing roles.

Best Scientists Citing H. Clifford Lane

Trending Scientists

Recently Published Articles